Erik Stoops

Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer’s disease

Shorena Janelidze, Divya Bali, Nicholas J. Ashton et al. · Brain · 2022 · 470 citations · Full text

Aging, Neurochemical Biomarkers, P-tau Biomarkers +20

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease

Pratishtha Chatterjee, Steve Pedrini, Erik Stoops et al. · Translational Psychiatry · 2021 · 443 citations · Full text

Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s <i>continuum</i> when only subtle changes in Aβ pathology are detected

Marc Suárez‐Calvet, Thomas K. Karikari, Nicholas J. Ashton et al. · EMBO Molecular Medicine · 2020 · 392 citations · Full text

Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age

Courtney L. Sutphen, Mateusz S. Jasielec, Aarti R. Shah et al. · JAMA Neurology · 2015 · 289 citations · Full text

Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology

Inge M.W. Verberk, Elisabeth H. Thijssen, Jannet Koelewijn et al. · Alzheimer s Research & Therapy · 2020 · 251 citations · Full text